TaiMed Biologics Inc. (TPEX:4147)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
87.90
-2.20 (-2.44%)
Apr 2, 2025, 1:30 PM CST

TaiMed Biologics Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-201.83-194.81-269.29-470.93-183.3
Upgrade
Depreciation & Amortization
150.1150.67151.73152.13137.12
Upgrade
Other Amortization
4.184.724.724.532.66
Upgrade
Loss (Gain) From Sale of Assets
2.32--24.187.84
Upgrade
Loss (Gain) From Sale of Investments
-29.05122.81-26.7663.13
Upgrade
Stock-Based Compensation
25.3610.5112.2710.2216.68
Upgrade
Other Operating Activities
80.785.82168.85101.38-15.5
Upgrade
Change in Accounts Receivable
57.47-62.2459.5497.94-53.59
Upgrade
Change in Inventory
185.47110.85-382.8414.84-384.99
Upgrade
Change in Accounts Payable
-12.7413.41-122.49116.79-130.24
Upgrade
Change in Unearned Revenue
-113.31-27.93-339.16113.9183.16
Upgrade
Change in Other Net Operating Assets
-557.36-65.64-11.33-349.5255.09
Upgrade
Operating Cash Flow
-379.55-25.6-605.21-211.28-201.94
Upgrade
Capital Expenditures
-8.06-6.15-3.56-9.69-53.61
Upgrade
Sale of Property, Plant & Equipment
---0.412
Upgrade
Sale (Purchase) of Intangibles
-11.3--1.21-3.87-332.16
Upgrade
Investment in Securities
-695.39-12.88110.88204.07273.36
Upgrade
Other Investing Activities
-0.12.58--1.25
Upgrade
Investing Cash Flow
-714.84-16.46106.12190.92-109.16
Upgrade
Short-Term Debt Issued
--200--
Upgrade
Long-Term Debt Issued
----536
Upgrade
Total Debt Issued
--200-536
Upgrade
Short-Term Debt Repaid
-200----
Upgrade
Long-Term Debt Repaid
-28.98-16.05-1.98-1.93-1.91
Upgrade
Total Debt Repaid
-228.98-16.05-1.98-1.93-1.91
Upgrade
Net Debt Issued (Repaid)
-228.98-16.05198.02-1.93534.09
Upgrade
Issuance of Common Stock
1,64535.2810.314.711.95
Upgrade
Other Financing Activities
-4.27-0.050.01-
Upgrade
Financing Cash Flow
1,41219.23208.382.79536.04
Upgrade
Foreign Exchange Rate Adjustments
11.54-0.2813.21-2.9-5.78
Upgrade
Net Cash Flow
329.22-23.1-277.51-20.47219.16
Upgrade
Free Cash Flow
-387.61-31.75-608.77-220.96-255.55
Upgrade
Free Cash Flow Margin
-63.52%-6.46%-108.13%-53.44%-35.37%
Upgrade
Free Cash Flow Per Share
-1.45-0.13-2.41-0.88-1.01
Upgrade
Cash Interest Paid
12.7114.769.887.443.84
Upgrade
Levered Free Cash Flow
-268.4782.39-217.42-191.55-673.15
Upgrade
Unlevered Free Cash Flow
-260.5991.65-211.11-186.9-670.59
Upgrade
Change in Net Working Capital
263.22-35.8255.1536.24358.31
Upgrade
Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.